LPCN-1148

N/A

Report date: 2025/06/06 16:48:29
NME

Base Information

Drug NameLPCN-1148
Drug Alias NameLPCN-1148
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor agonistsTestosterone replacements
TargetsAndrogen Receptor
Therapy Area/IndicationsSarcopeniaLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipocine Inc
Inactive CompaniesN/A
Active IndicationsSarcopeniaLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A